Pfizer's 2024 revenue forecast below Wall Street estimate
Dec 13 (Reuters) - Pfizer PFE.N on Wednesday forecast
2024 revenue that was below Wall Street expectations, and
increased its target for cost cuts by $500 million.
The U.S. drugmaker expects its annual revenue to be in the
range of $58.5 billion to $61.5 billion compared with analysts'
average estimate of $63.07 billion.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))